An immunomodulatory role for CD4+CD25+ regulatory T lymphocytes in hepatitis C virus infection

The CD4+CD25+ regulatory T lymphocytes have been implicated in suppressing T cell immune responses. Our aim was to characterize the frequency, phenotype, function, and specificity of CD4+CD25+ T cells in hepatitis C virus (HCV) infection. Peripheral CD4+CD25+ cells from recovered (n = 15), chronic infected (n = 30), and normal control (n = 15) subjects were analyzed ex vivo for quantitation, phenotype, and effect on HCV‐specific interferon gamma production and proliferation. CD4+CD25+ specificity was determined by intracellular cytokine staining for interleukin 10 (IL‐10). A higher proportion of CD4+CD25+ were found in chronic infection (mean, 3.02%) when compared with recovered (1.64%, P = .001) and normal controls (2.27%, P = .02). CD4+CD25+ cells display CD45ROhigh, CD45RAlow, CD28high, CD62Lhigh, and CD95high phenotype. HCV‐specific interferon gamma activity was enhanced in peripheral blood mononuclear cells depleted of CD4+CD25+ and suppressed in peripheral blood mononuclear cells enriched with CD4+CD25+. Depletion of CD4+CD25+ cells also enhanced HCV‐specific CD4+ and CD8+ T cell proliferation. Cytokine analysis suggested CD4+CD25+ cells secrete transforming growth factor beta (TGF‐β1) and IL‐10. The inhibitory role for TGF‐β1 was confirmed by anti–TGF‐β1. Transwell studies showed CD4+CD25+ mediated suppression to be dose dependent and requiring cell contact. CD4+CD25+ cells showed HCV‐specificity through IL‐10 production, with a frequency ranging from 1.9% to 5.3%. A positive correlation was detected between CD4+CD25+ T cell frequency and HCV RNA titer, whereas an inverse relation was found with liver inflammatory activity. In conclusion, CD4+CD25+ T lymphocytes constitute a highly differentiated population and appear to play a role in viral persistence by suppressing HCV‐specific T cell responses in a cell–cell contact manner. (HEPATOLOGY 2004;40:1062–1071.)

[1]  T. Hünig,et al.  Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist , 2003, European journal of immunology.

[2]  R. Steinman,et al.  Proliferating dendritic cell progenitors in human blood , 1994, The Journal of experimental medicine.

[3]  E. Pamer,et al.  Homeostasis of naïve, effector and memory CD8 T cells. , 2002, Current opinion in immunology.

[4]  M. Toda,et al.  Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. , 1998, International immunology.

[5]  P. Klenerman,et al.  Direct ex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection , 2001, European journal of immunology.

[6]  Philip J. R. Goulder,et al.  Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.

[7]  W. Strober,et al.  Cell Contact–Dependent Immunosuppression by Cd4+Cd25+Regulatory T Cells Is Mediated by Cell Surface–Bound Transforming Growth Factor β , 2001, The Journal of experimental medicine.

[8]  J. Demengeot,et al.  CD25+CD4+ regulatory T cells suppress CD4+ T cell‐mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice , 2002 .

[9]  H. Macdonald,et al.  The Early IL-4 Response to Leishmania major and the Resulting Th2 Cell Maturation Steering Progressive Disease in BALB/c Mice Are Subject to the Control of Regulatory CD4+CD25+ T Cells1 , 2002, The Journal of Immunology.

[10]  M. Ghany,et al.  Transcription-mediated amplification is more sensitive than conventional PCR-based assays for detecting residual serum HCV RNA at end of treatment , 2001, American Journal of Gastroenterology.

[11]  C. Ferrari,et al.  Immunopathogenesis of hepatitis C virus infection. , 1999, Journal of hepatology.

[12]  Fiona Powrie,et al.  Cytotoxic T Lymphocyte–Associated Antigen 4 Plays an Essential Role in the Function of Cd25+Cd4+ Regulatory Cells That Control Intestinal Inflammation , 2000, The Journal of experimental medicine.

[13]  S. Raghavan,et al.  Antigen‐Specific In Vitro Suppression of Murine Helicobacter pylori‐Reactive Immunopathological T Cells by CD4+CD25+ Regulatory T Cells , 2004, Scandinavian journal of immunology.

[14]  A. Sharpe,et al.  B7/CD28-Dependent CD4+CD25+ Regulatory T Cells Are Essential Components of the Memory-Protective Immunity to Candida albicans1 , 2002, The Journal of Immunology.

[15]  Ethan M. Shevach,et al.  CD4+CD25+ suppressor T cells: more questions than answers , 2002, Nature Reviews Immunology.

[16]  Y. Liaw,et al.  Detection of type 2‐like T‐helper cells in hepatitis C virus infection: Implications for hepatitis C virus chronicity , 1997, Hepatology.

[17]  M. Cucchiarini,et al.  Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C. , 2000, The Journal of infectious diseases.

[18]  M. Davis,et al.  Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[19]  F. Powrie,et al.  Control of intestinal inflammation by regulatory T cells. , 2001, Microbes and infection.

[20]  J. Shimizu,et al.  Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance , 2002, Nature Immunology.

[21]  S. Sakaguchi Regulatory T cells: mediating compromises between host and parasite , 2003, Nature Immunology.

[22]  G. Freeman,et al.  The B7–CD28 superfamily , 2002, Nature Reviews Immunology.

[23]  Ethan M. Shevach,et al.  Suppressor Effector Function of CD4+CD25+ Immunoregulatory T Cells Is Antigen Nonspecific , 2000, The Journal of Immunology.

[24]  Y. Belkaid,et al.  CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity , 2002, Nature.

[25]  A. B. Lyons,et al.  Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. , 2000, Journal of immunological methods.

[26]  G. Freeman,et al.  CD4+CD25high Regulatory Cells in Human Peripheral Blood1 , 2001, The Journal of Immunology.

[27]  J. Bijlsma,et al.  Antigen‐specific T cell suppression by human CD4+CD25+ regulatory T cells , 2002, European journal of immunology.

[28]  T. Sugie,et al.  Immunosuppression by CD4+ regulatory T cells induced by chronic retroviral infection , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[29]  T. Mak,et al.  Immunologic Self-Tolerance Maintained by Cd25+Cd4+Regulatory T Cells Constitutively Expressing Cytotoxic T Lymphocyte–Associated Antigen 4 , 2000, The Journal of experimental medicine.

[30]  G. Davis,et al.  Long‐term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti‐inflammatory effect , 2003, Hepatology.

[31]  K. Sugimoto,et al.  Suppression of HCV‐specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection , 2003, Hepatology.

[32]  N. Gruener,et al.  Detection of functionally altered hepatitis C virus‐specific CD4+ T cells in acute and chronic hepatitis C , 2003, Hepatology.

[33]  A. Rudensky,et al.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.

[34]  F. Liew,et al.  CD4+CD25+ Regulatory T Cells Suppress Differentiation and Functions of Th1 and Th2 Cells, Leishmania major Infection, and Colitis in Mice1 , 2003, The Journal of Immunology.